secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001104659-26-019827
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zura Bio prices $125M public offering of 18.2M shares at $6.25 and 1.8M pre-funded warrants
--------------------------------------------------------------------------------

- Offering: 18.2M Class A ordinary shares at $6.25/share, plus 1.8M pre-funded warrants at $6.249 each.
- Net proceeds expected ~$134.6M; underwriters' option for 3M additional shares exercised in full.
- Preliminary cash and equivalents as of Dec 31, 2025: ~$109.4M.
- Total outstanding ordinary shares after offering (excl. pre-funded warrants) ~94.9M.
- Offering expected to close Feb 26, 2026; joint bookrunners: Leerink, Piper Sandler, Cantor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465926019827/0001104659-26-019827-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465926019827/tm267297d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-019827

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer